ZEN Trial Shows DES to Be Safe and Feasible for ED, But Challenges Remain
December 25, 2012—Jason H. Rogers, MD, and coprincipal investigators Krishna Rocha-Singh, MD, and Irwin Goldstein, MD, published 6-month follow-up results from the first-in-man ZEN trial in the Journal of the American College of Cardiology (2012;60:2618–2627). The ZEN trial findings demonstrate that the use of drug-eluting stents to treat erectile dysfunction (ED) is both feasible and safe. However, Dr. Rogers explained that challenges remain and further study is needed before this treatment is more widely utilized.
